EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.

Although the rate of perinatal HIV infection is low, more than 50% of HIV infections in infants before age 1 year occurred in those who did not receive postnatal prophylaxis.

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

Novo Nordisk (NYSE:NVO) is one of the most profitable value stocks to buy according to analysts. On July 25, Novo Nordisk ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

By integrating STI management and PrEP into one seamless service, F*STI is set to redefine access to sexual health resources ...

R ita Pender has recently stepped down as IGPNEA Chair to become interim Director of Nursing Education within the Association ...

Debbie with a D sings, dances, twirls light-up batons and hosts 60-second health chats at a popular Bourbon Street gay bar.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Panelists discuss how the unprecedented 5-year progression-free survival benefit (60% vs 8%) demonstrated in the CROWN trial ...